Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: May 29, 2025
Neurofilament Light Chain and Multiple Sclerosis: Building a Neurofoundational Model of Biomarkers and Diagnosis.
Journal: Neurology international
Published: January 27, 2025
Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder: a case series report.
Journal: Frontiers in immunology
Published: November 12, 2024
Busting barriers for rare disease-A successful model of breaking barriers with payors for patient access to novel NMOSD therapeutics.
Journal: Multiple sclerosis and related disorders
Published: April 30, 2024
Showing 1-4 of 4
Last Updated: 09/26/2026